Von Willebrand Factor as a New Noninvasive Predictor of Clinically Significant Portal Hypertension and Mortality in Liver Cirrhosis

被引：0
|
作者：
Ferlitsch, Monika
Reiberger, Thomas
Hoke, Matthias
Salzl, Petra
Ulbrich, Gregor
Payer, Berit A.
Trauner, Michael H.
Peck-Radosavljevic, Markus
Ferlitsch, Arnulf
机构：
来源：
GASTROENTEROLOGY | 2012年 / 143卷 / 03期
关键词：
D O I：
10.1053/j.gastro.2012.07.082
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E26 / E26
页数：1
相关论文
共 50 条
  • [1] Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
    Ferlitsch, Monika
    Reiberger, Thomas
    Hoke, Matthias
    Salzl, Petra
    Schwengerer, Bernadette
    Ulbrich, Gregor
    Payer, Berit Anna
    Trauner, Michael
    Peck-Radosavljevic, Markus
    Ferlitsch, Arnulf
    HEPATOLOGY, 2012, 56 (04) : 1439 - 1447
  • [2] Von Willebrand factor predicts clinically significant portal hypertension in patients with liver cirrhosis
    Homoncik, M.
    Ferlitsch, A.
    Reiberger, T.
    Ulbrich, G.
    Gangl, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S114 - S115
  • [3] Is von Willebrand factor a predictive parameter for clinically significant portal hypertension in patients with liver cirrhosis?
    Homoncik, Monika
    Ferlitsch, Arnulf
    Ulbrich, Gregor
    Reiberger, Thomas
    Gangl, Alfred
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2007, 46 (04) : 590A - 591A
  • [4] von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis
    Wu, Hao
    Yan, Shiping
    Wang, Guangchuan
    Cui, Shaobo
    Zhang, Chunqing
    Zhu, Qiang
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1160 - 1169
  • [5] Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis
    Berzigotti, Annalisa
    Gilabert, Rosa
    Abraldes, Juan G.
    Nicolau, Carlos
    Bru, Concepcion
    Bosch, Jaime
    Garcia-Pagan, Juan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1159 - 1167
  • [6] von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis
    Zou, Ziyuan
    Yan, Xinwen
    Li, Cheng
    Li, Xiaofeng
    Ma, Xiaofen
    Zhang, Chunqing
    Ju, Shenghong
    Tian, Junzhang
    Qi, Xiaolong
    BMJ OPEN, 2019, 9 (08):
  • [7] von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
    Georgios N Kalambokis
    Gerasimos Baltayiannis
    Dimitrios Christodoulou
    World Journal of Gastroenterology, 2016, (19) : 4786 - 4788
  • [8] von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis
    Kalambokis, Georgios N.
    Baltayiannis, Gerasimos
    Christodoulou, Dimitrios
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (19) : 4786 - 4788
  • [9] Clinically significant portal hypertension in chronic liver disease: Always cirrhosis?
    Rodrigues, S.
    Berzigotti, A.
    Montani, M.
    De Gottardi, A.
    Bosch, J.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S734 - S734
  • [10] Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis
    Wang, Yizhe
    Zhao, Luxiang
    Zheng, Zhuozhao
    Zhang, Yu
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 2022
12345